Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Guardant Health, Inc.

Get SEC filing alerts via email and in your feed for Guardant Health, Inc.

GH

Guardant Health, Inc.

About Guardant Health, Inc.

Guardant Health, Inc. is a precision oncology company providing blood and tissue tests for cancer detection, monitoring, and therapy selection. Its core offerings include liquid biopsies, early detection screens, and companion diagnostics, serving patients, clinicians, and biopharmaceuticals globally. The company leverages advanced sequencing, AI, and real-world data to improve cancer outcomes and supports drug development and research through its comprehensive testing platform.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Guardant Health, Inc.

1
1
Guardant Health, Inc. Guardant Health Reports 48% Revenue Growth to $301.7 Million in Q1 2026

Via official filing (AI summary) | 29 days ago | 0 comments

2
1
Guardant Health, Inc. Guardant Health Reports $982 Million Revenue for Fiscal Year 2025, Despite $416.3 Million Net Loss

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
Guardant Health, Inc. Guardant Health Reports 39% Revenue Growth to $265.2 Million in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Guardant Health, Inc. Guardant Health Reports 31% Revenue Growth to $232.1 Million in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Guardant Health, Inc. Guardant Health Reports $203.5 Million Revenue in Q1 2025, Net Loss of $95.2 Million

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Guardant Health, Inc. Guardant Health Reports 34% Revenue Growth, Net Loss Widens in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments